1. Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives
   A. Khoo et al, 2024, International Journal of Molecular Sciences CrossRef
2. Diabetes and pancreatic cancer: Exploring the two-way traffic
   Ayan Roy et al, 2021, World Journal of Gastroenterology CrossRef
3. Peroxisome proliferator activated receptor gamma in human placenta may mediate the adverse effects of phthalates exposure in pregnancy
   Yujing Huang et al, 2018, Reproductive Toxicology CrossRef
4. ROSIGLITAZONE, A REPURPOSED DRUG AS ANTICANCER AGENT: A REVIEW
   Binita Patel et al, 2023, Towards Excellence CrossRef
5. Combining bioinformatics techniques to explore the molecular mechanisms involved in pancreatic cancer metastasis and prognosis
   Jia‐Sheng Xu et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
6. ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4
   Tianxing Zhou et al, 2022, Gut CrossRef
7. Apo-10’-lycopenoic acid inhibits cancer cell migration and angiogenesis and induces peroxisome proliferator-activated receptor γ
   Junrui Cheng et al, 2018, The Journal of Nutritional Biochemistry CrossRef
8. PTEN, MMP2, and NF-κB and Regulating MicroRNA-181 Aggravate Insulin Resistance and Progression of Diabetic Nephropathy: A Case-Control Study
   Manoj Khokhar et al, 2023, Kidney and Dialysis CrossRef
9. VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin
   Yuhui Wang et al, 2018, Molecules CrossRef
10. A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies
    Paulina Nowak et al, 2023, International Journal of Molecular Sciences CrossRef
11. Quercetin and its nanoformulations as promising agents for lung cancer treatment: A focus on molecular mechanisms
    Reza Arefnezhad et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
12. DHA- and EPA-Enriched Phosphatidylcholine Suppress Human Lung Carcinoma 95D Cells Metastasis via Activating the Peroxisome Proliferator-Activated Receptor γ
    Haowen Yin et al, 2022, Nutrients CrossRef
13. PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma
    Ann E. Zeleniak et al, 2018, Neoplasia CrossRef
14. DHA/EPA-Enriched Phosphatidylcholine Suppresses Tumor Growth and Metastasis via Activating Peroxisome Proliferator-Activated Receptor γ in Lewis Lung Cancer Mice
    Yuanyuan Liu et al, 2021, Journal of Agricultural and Food Chemistry CrossRef
15. Anti‐tumor effects of a nonsteroidal anti‐inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator‐activated receptor gamma and suppressing matrix metalloproteinase‐2 expression
    Takashi Higuchi et al, 2018, Cancer Medicine CrossRef